Announcements

ReACH Director, Dr. Barbara J. Turner featured on Texas Public Radio's Texas Standard

On Friday, March 31st, Dr. Barbara J. Turner, the Director of the Center for Research to Advance Community Health (ReACH) will be featured on the Texas Public Radio show Texas Standard to discuss a recently published study that looks at how much the Hispanic community knows about chronic pain.  Dr. Turner and her team conducted a population-based survey representing 8.8 million Hispanic residents of five Southwestern states who did not have chronic pain.  The data from this study reveal serious gaps in knowledge about chronic pain including misunderstanding about relying on narcotics to treat the disease. This is the first study to reveal poor knowledge about chronic pain in a large population of Americans and reinforces the urgency of launching a broad-based educational campaign about chronic pain and its care. 
 
 

ReACH Scholar Bertha "Penny" Flores, PhD, APRN, WHNP-BC Selected for the National Hispanic Health Foundation (NHHF) PCORI Hispanic Patient-Centered Health Research Mentorship Program

ReACH Scholar Bertha "Penny" Flores, PhD, APRN, WHNP-BC was recently selected for the the National Hispanic Health Foundation (NHHF) PCORI Hispanic Patient-Centered Health Research Mentorship Program. This unique mentorship and training program provides individualized mentoring by Hispanic senior faculty researchers, networking with PCOR experts and other researchers in Hispanic health equity, skills building for career development, a two day in-person PCOR training with a special session to present your research.  Congratulations Dr. Flores!

Bertha "Penny" Flores PhD, APRN, WHNP-BC Awarded KL2 Grant

We are pleased to announce that ReACH Scholar,  Penny Flores PhD, APRN, WHNP-BC  has been awarded a KL2 grant.  Congratulations on this exciting achievement Dr. Flores! 

 

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX

78229

 

Tel: 210-562-5551

Fax: 210-562-5560

Christopher R. Frei, PharmD, MSc, FCCP, BCPS

  • Attridge RL*, Linn WD, Ryan L, Koeller JM, Frei CR. Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity. Journal of Clinical Lipidology 6:19-26, 2012. 
  • Mortensen EM*, Nakashima B, Cornell J, Copeland LA, Pugh MJ, Anzueto A, Good C, Restrepo MI, Downs JR, Frei CR, Fine MJ. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clinical Infectious Diseases 55(11):1466-73, 2012.
  • Hall RG II*, Guiliano CA, Haase KK, Hazlewood KA, Frei CR, Forcade NA, Brouse SD, Bell T, Bedimo RJ, Alvarez CA. Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Infectious Diseases 12:104, 2012 (doi:10.1186/1471-2334-12-104). [PMCID: PCM3532187] 
  • Daniels KR, Frei CR*. The United States’ progress toward eliminating catheter-related bloodstream infections: Incidence, mortality, and hospital length of stay from 1996 to 2008. American Journal of Infection Control 41:118-121, 2013. [PMID: 22748842]
  • Hall RG II*, Hazelwood KA, Brouse SD, Guiliano CA, Haase KK, Frei CR, Forcade NA, Bell T, Bedimo RJ, Alvarez CA. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Pharm Toxicol 14:12, 2013. 
  • Nasar A, Ryan L, Frei CR, Cota JM, Wiederhold NP*. Influence of serum and albumin on echinocandin in vitro potency and pharmacodynamics. Current Fungal Infection Reports 7:89-95, 2013.
  • Mansi IA*, Mortensen EM, Pugh MJ, Wegner M, Frei CR. Incidence of musculoskeletal and neoplastic diseases in patients on statin therapy: results of a retrospective cohort analysis. The American Journal of the Medical Sciences 345:343-348, 2012. 
  • Oramasionwu CU, Morse GD, Lawson KA, Brown CM, Koeller JM, Frei CR*. “Hospitalizations for cardiovascular disease in African-Americans and Whites with HIV/AIDS. Population Health Management 16:201-207, 2012.
  • Mansi I*, Frei CR, Pugh MJ, Mortensen EM. Psychological diseases and statin use: a propensity score-matched analysis. Pharmacotherapy 33:615-626, 2013. [PMCID: PMC3676864]
  • Labreche MJ, Lee GC, Attridge RT, Mortensen EM, Koeller J, Du LC, Nyren NR, Trevino LB, Trevino SB, Pena J, Mann, MW, Munoz A, Marcos Y, Rocha G, Koretsky S, Esparza S, Finnie M, Dallas SD, Frei CR*. Treatment failure and associated costs in patients with methicillin-resistant Staphylococcus aureus skin and soft tissue infections treated in primary care settings: A South Texas Ambulatory Research Network study. Journal of the American Board of Family Medicine 26:508-517, 2013.  *** This issue of the journal was highlighted by the Agency for Healthcare Research and Quality (AHRQ).
  • Mansi I*, Frei CR, Pugh MJ, Makris U, Mortensen EM. Statins and musculoskeletal conditions, arthropathies, and injuries. JAMA Internal Medicine 173:1-10, 2013.
  • Schmidt T, Battafarano D, Mortensen EM, Frei CR, Mansi I*. Frequency of development of connective tissue disease in statin-users vs. non-users. American Journal of Cardiology 112:883-888, 2013.
  • Magulick J, Frei CR, Ali S, Mortensen EM, Pugh MJ, Oramasionwu CU, Daniels KR, Mansi IA*. The effect of statin therapy on the incidence of infections: a retrospective cohort analysis. The American Journal of the Medical Sciences 347(3):211-216, 2013. [PMCID: PMC3664245]
  • Leuschen J, Mortensen EM, Frei CR, Mansi EA, Panday V, Mansi I*. Association of statin use with cataracts: a propensity score-matched analysis. JAMA Ophthalmology 131(11):1427-1434, 2013. [PMID: 24052188].
  • Daniels KR, Lee GC, Frei CR*. Trends in catheter-associated urinary tract infections among a national cohort of hospitalized adults: 2001 to 2010. American Journal of Infection Control 42(1):17-22, 2013.
  • Bussey HI, Bussey M, Bussey-Smith KL, Frei CR. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low dose vitamin K with genomic considerations: a pilot study. Pharmacotherapy 33(11):1136-1146, 2013.
  • Meyer S, Frei CR, Daniels KR, Forcade NA, Bussey M, Bussey-Smith KL, Bussey HI. Impact of a new method of warfarin management on patient satisfaction, time, and cost. Pharmacotherapy 33 (11):1147-1155, 2013.
  • Johnson CS, Frei CR, Metersky ML, Anzueto AR, Mortensen EM*. Non-invasive mechanical ventilation and mortality in elderly immunocompromised patients hospitalized with pneumonia: a retrospective cohort study. BMC Pulmonary Medicine 14:7, 2014.
  • Bell AM, Corral M, Penrod JR, Zhang Y, Frei CR, Ryan L, Salvati M, Koeller JM. New drugs not major cost drivers for lung cancer care. The American Journal of Pharmacy Benefits (In Press).
  • Ward IM, Mortensen EM, Battafarano DE, Frei CR, Mansi I*. Association of statins and risk of fractures in a military health system: a propensity score-matched analysis. Annals of Pharmacotherapy (In Press).